Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 9.386.306.235.123.73

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.38 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12
Mar20203.73

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12
37.27
Mar2020 3.73 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,043.4 Cr -6.8% -30.4% -15.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-6.8%

-30.4%

-15.7%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses